Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-26

Clinical Trial Update: The Study on the Mechanism of Radiotherapy-elicited Immune Response

View source ↗

Summary

A study at Fudan University is investigating how radiotherapy elicits an immune response in esophageal cancer and is currently recruiting participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fudan University | Conditions: Esophageal Carcinoma Salivary Gland Type, Radiotherapy | Status: RECRUITING